post partum hemorrhage

Reading File
Finding Sources
Searching PubMed

"postpartum hemorrhage"[MeSH Terms] AND management

Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Searching Images

postpartum hemorrhage uterine atony management algorithm

Reading File
Reading File
Now I have comprehensive information. Let me compile the full answer.

Postpartum Hemorrhage (PPH)

Definition

PPH has two definitions in current use:
  • Classical: Blood loss >500 mL after vaginal delivery or >1,000 mL after cesarean delivery within 24 hours of birth
  • ACOG (current): Blood loss ≥1,000 mL after any mode of delivery, or any volume of blood loss accompanied by signs/symptoms of hypovolemia within 24 hours of birth
Primary (early) PPH: Within the first 24 hours of delivery Secondary (late) PPH: 24 hours to 6 weeks postpartum
Physiologically, plasma volume increases ~40% and RBC volume ~25% by end of third trimester — so up to 30% total blood volume loss may occur before blood pressure drops. The first sign may be only a mild rise in pulse rate.

Causes — The "4 Ts"

CauseDetailsFrequency
Tone (Uterine atony)Most common cause; >70% of PPH~70–80%
TissueRetained placenta/fragments, placenta accreta spectrum~10%
TraumaCervical/vaginal/perineal lacerations, uterine rupture, uterine inversion~20%
ThrombinCoagulopathy (inherited or acquired/DIC)Uncommon
Secondary PPH causes: Uterine subinvolution at the placental site, retained placental tissue, genital tract wounds, uterogenital infection.

Risk Factors

For uterine atony:
  • Uterine overdistension (polyhydramnios, multiple gestation, macrosomia)
  • Prolonged or rapid labor
  • High parity (multiparity)
  • Labor induction/augmentation with oxytocin or tocolytics
  • Chorioamnionitis / intraamniotic infection
  • Hypertensive disorders of pregnancy
For cesarean PPH:
  • Preeclampsia, obesity, general anesthesia, prior PPH
For uterine rupture:
  • Prior uterine surgery (most significant risk factor)
  • Obstructed labor, abnormal fetal lie, grand multiparity

Etiologies Table (Barash Clinical Anesthesia)

CategorySpecific Causes
Uterine atonyOverdistension, infection, prolonged labor
Genital tract traumaEpisiotomy, perineal/vaginal/cervical lacerations
Retained productsPlacenta fragments
Abnormal placentationPlacenta accreta / increta / percreta
Coagulation defectsInherited (e.g., vWD) or acquired (DIC)
Uterine inversionOften from mismanaged 3rd stage

Management

Initial Resuscitation (All PPH)

  1. Monitor vitals frequently; establish large-bore IV access
  2. Fluid resuscitation — Lactated Ringer's initially
  3. Labs: CBC, type & crossmatch, fibrinogen, PT/PTT, platelet count
  4. Supplemental oxygen to maximize cellular delivery
  5. Prepare for blood transfusion
  6. Non-pneumatic antishock garments can reduce blood loss in resource-limited or transport settings

Stepwise Treatment by Cause

🔴 Uterine Atony (Most Common)

Step 1 — Uterotonic Agents:
DrugDoseKey Precautions
Oxytocin (1st line)20–30 U in 1L IV fluid ≤100 mU/min; or bolus 1–3 IU IV + infusionAvoid rapid bolus (hypotension); risk of fluid overload
Methylergonovine0.2 mg IM q2–4hContraindicated in hypertension (causes vasoconstriction, severe HTN)
15-methyl PGF₂α (Carboprost/Hemabate)250 μg IM q15–90 min (max 8 doses)Avoid in asthma or cardiovascular disease; monitor O₂ sat
Misoprostol800–1000 μg rectally or transvaginallyFor refractory cases; useful where IV drugs unavailable
Step 2 — Bimanual uterine massage/compression alongside pharmacotherapy
Step 3 — If uterus remains atonic after pharmacotherapy:
  • Uterine tamponade: Bakri balloon or Foley catheter (especially for low placentation site bleeding)
  • Uterine packing with sterile gauze
  • Selective pelvic vessel embolization (where available)
Step 4 — Surgical (laparotomy):
  • Identify occult intraabdominal sources
  • Arterial ligation (uterine artery, internal iliac artery)
  • B-Lynch compression sutures — vertical sutures that mechanically compress the uterine corpus
  • Peripartum hysterectomy (last resort for refractory atony)

🔴 Retained Placenta / Accreta Spectrum

  • Manual exploration and removal
  • Placenta accreta: average blood loss 3–5 L; planned cesarean hysterectomy at 34–36 weeks under elective conditions is preferred
  • Emergency embolectomy or hemostatic B-Lynch sutures if unplanned

🔴 Lacerations

  • Repair under adequate light, exposure, and assistance
  • Continuing hemorrhage with a firm fundus = look for hidden laceration

🔴 Uterine Inversion

  • Immediate manual replacement: grasp uterus in palm, thumb anterior, push firmly back into abdominal cavity, hold for several minutes
  • IV hydration briskly before and during
  • Tocolytics (e.g., magnesium sulfate 0.25 mg IV) may assist repositioning
  • Correction often requires general anesthesia

🔴 Uterine Rupture

  • Immediate surgery; high maternal and fetal mortality risk
  • Primary risk factor: prior cesarean section

Prevention (Active Management of 3rd Stage)

Active management reduces PPH incidence by two-thirds:
  1. Early oxytocin administration (10 U IM or dilute IV) after delivery of anterior shoulder or immediately after birth
  2. Early cord clamping and cutting
  3. Controlled cord traction

Surgical Images

B-Lynch compression sutures — diagram and intraoperative view
B-Lynch compression sutures: puncture points and intraoperative appearance — used when uterotonic drugs fail
Bilateral uterine artery ligation, B-Lynch suture, and final involution
Surgical sequence: (A) uterine artery ligation, (B) B-Lynch suture application, (C) final contracted uterus after hemostasis
Double-balloon tamponade for uterine inversion + atony
Double-balloon tamponade with Isthmus Vertical Compression Sutures (IVCS) for uterine inversion and severe atony

Recent Evidence (2025 Cochrane Updates)

  • Uterotonic agents (PMID 40237648): 2025 Cochrane network meta-analysis confirms combination uterotonics (e.g., oxytocin + carbetocin, or oxytocin + misoprostol) are superior to oxytocin alone for PPH prevention.
  • Blood product transfusion (PMID 39911088): 2025 Cochrane review on optimal transfusion strategies in PPH management — current evidence base for ratio-based massive transfusion protocols remains limited in obstetric-specific populations.

Sources: Creasy & Resnik's Maternal-Fetal Medicine, Tintinalli's Emergency Medicine, Textbook of Family Medicine 9e, Barash Clinical Anesthesia 9e
This is a shared conversation. Sign in to Orris to start your own chat.